Day: November 21, 2024

ISELIN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that Kim Strignile has joined the Human Resources team as Senior Vice President, HR Business Partner Director. Ms. Strignile will lead the bank’s HR Business Partner and Talent Acquisition teams, playing a pivotal role in driving its people strategy.In addition, Ms. Strignile will serve as a trusted advisor and change agent, collaborating closely with Provident’s leadership team to cultivate a high-performing culture and enhance the employee experience. Together with her team, she will champion a culture of continuous growth and development. “Kim is a proven leader with expertise in advancing workforce and talent strategies, significantly improving career pathing, development, and succession...

SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) — Redhook Ale Brewery (“Redhook”), Seattle’s pioneering craft brewery and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), officially presents their new partnership with the Montlake Futures NIL Collective, supporting student-athletes at the University of Washington (UW). Together, they launched Montlake Gameday Gold Lager, the Official Beer of the Montlake Futures NIL Collective. This unique lager stands out as the only beer dedicated to supporting UW student athletes. Montlake Gameday Gold Lager debuted at Husky Stadium during home games and is available at Redhook Brewlab and Seattle-area grocery stores. This strategic partnership aims to empower UW student-athletes and strengthen UW Athletics while offering fans a new, delicious lager.“We are pleased to have two...

Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by Siemens to Showcase Advancing Technologies in the MRI Space The RSNA Edition Coincides With the Annual Meeting of the Radiology Society of North America (RSNA) BROOMFIELD, Colo., Nov. 21, 2024 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is featured in the RSNA Edition of Siemens Healthineers magazine, MAGNETOM Flash. The RSNA annual meeting is December 1-4, 2024. The inclusion of Nociscan...

WithSecure Corporation, Press release, 22 November 2024 at 15:00 EET WithSecure publishes its new medium-term financial target WithSecure Corporation has defined a new medium-term financial target for the company. Target is applicable on the Elements Company segment. In line with WithSecure’s strategic objectives, the new medium-term financial target is: Over the next three years (2025-2027), WithSecure will become a “Rule of 30+” company. The components of the target areAnnual revenue growth as percentage Adjusted EBITDA as percentage of revenue.WithSecure is targeting to reach a sum of the components that exceeds 30. WithSecure does not consider the medium-term financial target as market guidance for any given year. Contact information: Laura Viita Vice President, Controlling, Investor relations and Sustainability WithSecure Corporation Tel....

– In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance compared to current synthetic graft treatment benchmarks – – Results were published in a premier peer-reviewed surgical journal sponsored by the American Medical Association – DURHAM, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced the publication of clinical results evaluating the efficacy and safety of the acellular tissue engineered vessel (ATEV) in the repair of extremity civilian and military injuries in JAMA Surgery, an American Medical Association peer-reviewed journal. The publication “Bioengineered Human Arteries for the...

The Company’s class A ordinary shares will begin trading on a split-adjusted basis on November 25, 2024 FOSTER CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, announced today that it will affect a 1-for-100 reverse share split (“Reverse Share Split”) of its class A ordinary shares, par value $0.0001 per share (“Old Shares”), which will become effective at 12:01a.m. Eastern Time on Monday, November 25, 2024 (the “Effective Time”). The Company’s new class A ordinary shares, par value $0.01 per share (“New Shares”) will begin trading on a split-adjusted basis on the Nasdaq Stock Market at the open of trading on...

DALLAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — Asset Entities Inc. (“Asset Entities” or “the Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary Payment Platform company, announced today that famed dog behavioralist Jas Leverette, star of the Netflix show Canine Intervention, has selected Asset Entities to Design, Develop and Manage his dog training community server on the Discord social community platform, and has entered into an agreement with the Company to collaborate on building a subscription-based digital dog training community on Discord. This new digital community will feature personal instruction from Jas and his team at his San Jose, California dog training facility, Cali K9, on such canine skills as obedience, socialization,...

HOLLYWOOD, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) — NV5, a provider of technology, certification, and consulting solutions, announced today that it has been awarded $14 million in recent multi-year infrastructure consulting contracts to support several municipalities across Southern California. NV5 was selected by a large Southern California county to deliver comprehensive not-at-risk construction management services to oversee transportation infrastructure improvements. The five-year contract will focus on transportation capital improvement and maintenance projects to increase traffic capacity and safety through construction management, quality assurance and control, and plan review services. Two Los Angeles County municipalities also selected NV5 for engineering, water resources, and not-at-risk construction management services....

MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a Phase 3 rare disease trial sponsored by global biopharmaceutical company, GSK. The hepatology study of an investigational medicine for cholestatic pruritus in primary biliary cholangitis (PBC) required 230 global participants, of which Science 37 was able to contribute almost half (17 – 47%) of the U.S. enrollment for the study. Recognizing that the available participant population for rare disease studies is often extremely limited and dispersed globally, GSK welcomed an innovative approach to expanding trial access—one that would also help patients overcome symptom-based barriers such as fatigue that make it challenging to adhere to frequent site...

FENIX Trophy co-founder Leonardo Aleotti attends the 42° MILANO INTERNATIONAL FICTS FESTIVAL awards ceremony with the documentary “The Amazing Adventures of Mr. Fenix (in the Lands of European Non-Professional Football)” by Gigi MammanaFENIX Trophy co-founder Leonardo Aleotti attends the 42° MILANO INTERNATIONAL FICTS FESTIVAL awards ceremony with the documentary “The Amazing Adventures of Mr. Fenix (in the Lands of European Non-Professional Football)” by Gigi Mammana (Brera Production)FENIX Trophy co-founder Leonardo Aleotti attends the 42° MILANO INTERNATIONAL FICTS FESTIVAL awards ceremony with the documentary “The Amazing Adventures of Mr. Fenix (in the Lands of European Non-Professional Football)” by Gigi Mammana (Brera Production) Dublin, Ireland and Milan, Italy, Nov. 21, 2024 (GLOBE NEWSWIRE) — Brera Holdings...